Vanda [VNDA] vs Regeneron [REGN] Detailed Stock Comparison
Vanda
NASDAQ
Loading...
Regeneron
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Vanda wins in 7 metrics, Regeneron wins in 11 metrics, with 0 ties. Regeneron appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Vanda | Regeneron | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 126.00 | 14.62 | Regeneron |
| Price-to-Book Ratio | 0.53 | 2.02 | Vanda |
| Debt-to-Equity Ratio | 2.39 | 9.04 | Vanda |
| PEG Ratio | 21.80 | 12.81 | Regeneron |
| EV/EBITDA | 0.61 | 12.41 | Vanda |
| Profit Margin (TTM) | -32.90% | 31.37% | Regeneron |
| Operating Margin (TTM) | -73.21% | 29.64% | Regeneron |
| EBITDA Margin (TTM) | N/A | 29.64% | N/A |
| Return on Equity | -13.01% | 15.34% | Regeneron |
| Return on Assets (TTM) | -9.88% | 6.66% | Regeneron |
| Free Cash Flow (TTM) | $-16.25M | $3.54B | Regeneron |
| Dividend Yield | N/A | 0.46% | N/A |
| 1-Year Return | -16.15% | -50.78% | Vanda |
| Price-to-Sales Ratio (TTM) | 1.27 | 4.33 | Vanda |
| Enterprise Value | $-56.28M | $55.42B | Regeneron |
| EV/Revenue Ratio | -0.28 | 3.90 | Vanda |
| Gross Profit Margin (TTM) | 94.80% | 85.58% | Vanda |
| Revenue per Share (TTM) | $3 | $133 | Regeneron |
| Earnings per Share (Diluted) | $-1.14 | $39.70 | Regeneron |
| Beta (Stock Volatility) | 0.73 | 0.33 | Regeneron |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Vanda vs Regeneron Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vanda | -1.58% | 3.81% | -8.40% | 10.94% | -2.24% | -9.54% |
| Regeneron | 2.55% | 3.09% | 5.92% | -0.78% | -14.65% | -18.85% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vanda | -16.15% | -57.87% | -59.10% | -61.95% | -32.61% | -55.05% |
| Regeneron | -50.78% | -6.14% | -4.14% | 10.10% | 2,431.23% | 6,768.76% |
Performance & Financial Health Analysis: Vanda vs Regeneron
| Metric | VNDA | REGN |
|---|---|---|
| Market Information | ||
| Market Cap | $257.63M | $61.52B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 486,410 | 1,012,030 |
| 90 Day Avg. Volume | 534,930 | 965,153 |
| Last Close | $4.36 | $580.41 |
| 52 Week Range | $3.81 - $5.55 | $476.49 - $1,211.20 |
| % from 52W High | -21.44% | -52.08% |
| All-Time High | $33.44 (Dec 03, 2018) | $1,211.20 (Aug 26, 2024) |
| % from All-Time High | -86.96% | -52.08% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.04% |
| Quarterly Earnings Growth | 0.04% | -0.03% |
| Financial Health | ||
| Profit Margin (TTM) | -0.33% | 0.31% |
| Operating Margin (TTM) | -0.73% | 0.30% |
| Return on Equity (TTM) | -0.13% | 0.15% |
| Debt to Equity (MRQ) | 2.39 | 9.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.23 | $287.55 |
| Cash per Share (MRQ) | $5.51 | $72.04 |
| Operating Cash Flow (TTM) | $-64,797,000 | $4.74B |
| Levered Free Cash Flow (TTM) | $-38,860,376 | $2.85B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.46% |
| Last 12-Month Dividend | N/A | $2.64 |
Valuation & Enterprise Metrics Analysis: Vanda vs Regeneron
| Metric | VNDA | REGN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 126.00 | 14.62 |
| Forward P/E | 21.80 | 12.81 |
| PEG Ratio | 21.80 | 12.81 |
| Price to Sales (TTM) | 1.27 | 4.33 |
| Price to Book (MRQ) | 0.53 | 2.02 |
| Market Capitalization | ||
| Market Capitalization | $257.63M | $61.52B |
| Enterprise Value | $-56,283,392 | $55.42B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -0.28 | 3.90 |
| Enterprise to EBITDA | 0.61 | 12.41 |
| Risk & Other Metrics | ||
| Beta | 0.73 | 0.33 |
| Book Value per Share (MRQ) | $8.23 | $287.55 |
Financial Statements Comparison: Vanda vs Regeneron
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VNDA | REGN |
|---|---|---|
| Revenue/Sales | $50.04M | $3.03B |
| Cost of Goods Sold | $3.52M | $464.30M |
| Gross Profit | $46.52M | $2.56B |
| Research & Development | $35.71M | $1.34B |
| Operating Income (EBIT) | $-41.03M | $591.70M |
| EBITDA | $-39.05M | $900.90M |
| Pre-Tax Income | $-37.37M | $905.00M |
| Income Tax | $-7.87M | $96.30M |
| Net Income (Profit) | $-29.49M | $808.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VNDA | REGN |
|---|---|---|
| Cash & Equivalents | $111.80M | $3.09B |
| Total Current Assets | $407.91M | $17.57B |
| Total Current Liabilities | $103.92M | $3.57B |
| Long-Term Debt | $7.35M | $2.70B |
| Total Shareholders Equity | $511.42M | $29.39B |
| Retained Earnings | $-203.79M | $32.38B |
| Property, Plant & Equipment | $12.48M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VNDA | REGN |
|---|---|---|
| Operating Cash Flow | $-27.01M | $1.36B |
| Capital Expenditures | $-436,000 | N/A |
| Free Cash Flow | $-33.58M | $773.60M |
| Debt Repayment | $-409,000 | N/A |
| Common Stock Repurchase | N/A | $-1.05B |
Short Interest & Institutional Ownership Analysis
| Metric | VNDA | REGN |
|---|---|---|
| Shares Short | 4.53M | 2.29M |
| Short Ratio | 8.86 | 2.55 |
| Short % of Float | 0.08% | 0.02% |
| Average Daily Volume (10 Day) | 486,410 | 1,012,030 |
| Average Daily Volume (90 Day) | 534,930 | 965,153 |
| Shares Outstanding | 58.31M | 109.62M |
| Float Shares | 49.48M | 97.91M |
| % Held by Insiders | 0.07% | 0.02% |
| % Held by Institutions | 0.79% | 0.91% |
Dividend Analysis & Yield Comparison: Vanda vs Regeneron
| Metric | VNDA | REGN |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.64 |
| Last 12-Month Dividend Yield | N/A | 0.46% |
| 3-Year Avg Annual Dividend | N/A | $0.88 |
| 3-Year Avg Dividend Yield | N/A | 0.14% |
| 3-Year Total Dividends | N/A | $2.64 |
| Ex-Dividend Date | N/A | Aug 18, 2025 |